Skip to content

Frontlight ResearchEarly access

Trial site

Oncovida (Site 2107)

Santiago, Region M. de Santiago 7500994, ChileNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Kidney cancer

Closed trials

Completed
Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)
NCT04626479· Phase 1/2· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Oncovida (Site 2107): trial site – Frontlight Research